452 related articles for article (PubMed ID: 10036965)
41. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
[TBL] [Abstract][Full Text] [Related]
42. Relation between markers for viral hepatitis and clinical features of Japanese patients with hepatocellular carcinoma: possible role of alcohol in promoting carcinogenesis.
Matsuda Y; Amuro Y; Higashino K; Hada T; Yamamoto T; Fujikura M; Yamaguchi K; Shimomura S; Iijima H; Nakano T
Hepatogastroenterology; 1995 Apr; 42(2):151-4. PubMed ID: 7545640
[TBL] [Abstract][Full Text] [Related]
43. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
44. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection.
Ayoola EA; Gadour MO
J Gastroenterol Hepatol; 2004 Jun; 19(6):665-9. PubMed ID: 15151622
[TBL] [Abstract][Full Text] [Related]
45. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
Tabor E
Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
[TBL] [Abstract][Full Text] [Related]
46. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
Yu MC; Yuan JM; Ross RK; Govindarajan S
Hepatology; 1997 Jan; 25(1):226-8. PubMed ID: 8985295
[TBL] [Abstract][Full Text] [Related]
47. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
Tamori A; Hayashi T; Shinzaki M; Kobayashi S; Iwai S; Enomoto M; Morikawa H; Sakaguchi H; Shiomi S; Takemura S; Kubo S; Kawada N
J Med Virol; 2009 Jun; 81(6):1009-14. PubMed ID: 19382258
[TBL] [Abstract][Full Text] [Related]
48. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
49. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
[TBL] [Abstract][Full Text] [Related]
50. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
[TBL] [Abstract][Full Text] [Related]
51. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.
Bréchot C; Jaffredo F; Lagorce D; Gerken G; Meyer zum Büschenfelde K; Papakonstontinou A; Hadziyannis S; Romeo R; Colombo M; Rodes J; Bruix J; Williams R; Naoumov N
J Hepatol; 1998 Aug; 29(2):173-83. PubMed ID: 9722197
[TBL] [Abstract][Full Text] [Related]
52. Angiogenic activity of hepatitis B and C viruses.
Vrancken K; Paeshuyse J; Liekens S
Antivir Chem Chemother; 2012 Jan; 22(4):159-70. PubMed ID: 22182803
[TBL] [Abstract][Full Text] [Related]
53. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
Di Bisceglie AM; Simpson LH; Lotze MT; Hoofnagle JH
J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758
[TBL] [Abstract][Full Text] [Related]
54. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
Yang WT; Wu LW; Tseng TC; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Liu CJ; Kao JH
Medicine (Baltimore); 2016 Mar; 95(10):e2995. PubMed ID: 26962809
[TBL] [Abstract][Full Text] [Related]
56. [Progression of liver disease in HCV co-infected HBV-DNA carrier].
Koike K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):671-6. PubMed ID: 15359883
[No Abstract] [Full Text] [Related]
57. Etiological and molecular profile of hepatocellular cancer from India.
Asim M; Sarma MP; Kar P
Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
[TBL] [Abstract][Full Text] [Related]
58. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues.
Urashima T; Saigo K; Kobayashi S; Imaseki H; Matsubara H; Koide Y; Asano T; Kondo Y; Koike K; Isono K
J Hepatol; 1997 Apr; 26(4):771-8. PubMed ID: 9126788
[TBL] [Abstract][Full Text] [Related]
59. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
60. [Comparison of hepatocellular carcinoma type C and B by quantitation of serum HCV-RNA and HBV-DNA using branched DNA probe assay].
Teramoto T; Iwabuchi S; Takatori M; Iino S
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):787-95. PubMed ID: 7563876
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
